Donald J. Santel - 30 Jul 2021 Form 4 Insider Report for Oyster Point Pharma, Inc.

Role
Director
Signature
/s/ Brandon Fenn, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 20:18:18 UTC
Next filing
13 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OYST Common Stock Award $0 +6,937 $0.000000 6,937 30 Jul 2021 Direct F1, F2
transaction OYST Common Stock Award $0 +3,177 +46% $0.000000 10,114 30 Jul 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OYST Stock Option (Right to Buy) Award $0 +10,405 $0.000000 10,405 30 Jul 2021 Common Stock 10,405 $14.25 Direct F4
transaction OYST Stock Option (Right to Buy) Award $0 +4,765 $0.000000 4,765 30 Jul 2021 Common Stock 4,765 $14.25 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 These RSUs will vest over three years (on the same day of the month as the grant date) with one-third (1/3) vesting annually, in each case subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2019 Equity Incentive Plan (the "Plan")) through each such date.
F3 These RSUs will vest on June 7, 2022, but will vest fully on the date of the Company's next annual meeting of stockholders held after the date of grant if not fully vested on such date, subject to the Reporting Person continuing to be a Service Provider through such date.
F4 One-third (1/3) of the shares subject to the option shall vest on the 12 month anniversary of the grant date and the remainder will vest at one-twentyfourth (1/24th) per month thereafter (on the same day of the month as the grant date), subject to the Reporting Person continuing to be a Service Provider through each such date.
F5 One-eleventh (1/11th) of the Shares subject to the Option shall vest monthly beginning on August 7, 2021 and on the same day monthly thereafter, but will vest fully on the date of the Issuer's next annual meeting of stockholders held after the date of grant if not fully vested on such date, subject to the Reporting Person continuing to be a Service Provider through each such date.